An RNA sequencing (RNA-seq) analysis comparing parental BRCA2-mutated cancer cells and olaparib-resistant cells identified SRY-box transcription factor 5 (SOX5) as one of the top candidate genes upregulated in olaparib-resistant cells compared to the corresponding parental cells. This evidence concerns the gene SOX5 and cancer.